Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Microenvironmental Extracellular Matrix Remodeling Driven by GATA2 and GATA3 Deficiency Impairs Lymphatic Recanalization.

Created on 30 Sep 2026

Authors

Tomomi Watanabe-Asaka, Moyuru Hayashi, Takuya Harada-Norikane, Mayu Nakamura, May Kouriki, Jun Takai, Satoshi Uemura, Takuo Hirose, Yoshiko Kawai

Published in

Journal of biochemistry. Sep 30, 2026. Epub Sep 30, 2026.

Abstract

GATA2 is a transcription factor that is essential for vascular and lymphatic development. GATA2 deficiency causes lymphatic malformations and lymphedema. Delayed lymphatic recanalization after popliteal lymph node removal in Gata2 heterozygous (Gata2+/-) mice is associated with collagen accumulation in the surrounding tissue. In this study, we investigated whether extracellular matrix (ECM) alterations contribute to lymphatic recanalization by analyzing subcutaneous tissue from Gata2+/- and Gata2 and Gata3 double heterozygous (Gata2+/-::Gata3+/-) mice. RNA-seq analysis revealed changes in ECM-related and adhesion-associated genes in both genotypes. Histological analyses demonstrated collagen accumulation and disorganized collagen bundles in Gata2+/-::Gata3+/- mice. Immunostaining further revealed reduced elastin fibers and decreased numbers of fibroblasts in subcutaneous tissues of Gata2+/- and Gata2+/-::Gata3+/- mice. These findings suggest that abnormalities in ECM organization, including altered collagen and elastin structures and reduced fibroblast populations, may underlie collagen accumulation and impaired lymphatic recanalization. Notably, Gata2+/-::Gata3+/- mice exhibited a patchwork-like dermal phenotype reflecting features of both single mutants, possibly owing to mosaic transcriptional regulation within the GATA gene network. The microenvironmental ECM structure plays an important role in lymphatic recanalization following lymphatic injury.

PMID:
42814018
Bibliographic data and abstract were imported from PubMed on 30 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement